「A study on the immunostimulatory effects of alarmin HMGN1 in cancer immunity」の関連論文
-
Tenascin C Aggravates Autoimmune Myocarditis via Dendritic Cell Activation and Th17 Cell Differentiation
-
Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma
-
GSK3 inhibitor enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance
-
Engineering a human IgG2 antibody stable at low pH
-
Studies on the roles of C-type lectin receptors in the homeostasis of the immune system
-
The lectin-like domain of thrombomodulin is a drug candidate for both prophylaxis and treatment of liver ischemia and reperfusion injury in mice
-
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
-
Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer
-
Studies on the pathological mechanism of alopecia areata in C3H/HeJ mouse model
-
Clinical efficacy of the combined treatment of anti-PD-L1 rat-bovine chimeric antibody with a COX-2 inhibitor in calves infected with Mycoplasma bovis
-
Highly potent antiausterity agents from Callistemon species from Egypt and their mechanism of action against the PANC-1 human pancreatic cancer cell line
-
ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells
-
Isolation of a human SARS-CoV-2 neutralizing antibody from a synthetic phage library and its conversion to fluorescent biosensors
-
A recombinant adenovirus vector containing the synNotch receptor gene for the treatment of triple-negative breast cancer
-
Retinoic acid receptor activity is required for the maintenance of type 1 innate lymphoid cells
-
Chemical biology studies on nucleic acid recognition, modification, and secondary structures
-
医薬品候補の潜在的供給源としての野生塩生植物の利用
-
Mechanisms by which Bacterial and Viral Pathogens cause Ovarian dysfunction
-
A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
-
Functional analysis of an opioid precursor gene expressed in regulatory T cells
-
The clinical significance of CXCL16 in the treatment of advanced non-small cell lung cancer
-
Involvement of Corticotropin-releasing Hormone-related Peptides in Cellular Stress Caused by Anticancer Drugs in Colorectal Cancer
-
Gut contractile organoids: a novel model system to study the cellular synchronization in gastrointestinal motility
-
Mechanisms of anti-inflammatory and anticancer effects of biologically active components of cinobufacini
-
Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model.
-
CD44v9 Induces Stem Cell-Like Phenotypes in Human Cholangiocarcinoma
-
Immunomodulatory effects of D-allose on cytokine production by plasmacytoid dendritic cells
-
Polysaccharides from Shiitake Culinary-Medicinal Mushroom Lentinus edodes (Agaricomycetes) Suppress pMLKL-Mediated Necroptotic Cell Death and Colitis in Mice
-
miR-142 induces accumulation of reactive oxygen species (ROS) by inhibiting pexophagy in aged bone marrow mesenchymal stem cells
-
Development of antisense oligonucleotides for suppressing breast cancer cell proliferation and the system for evaluating drug response of cardiomyocytes
-
Circulatory C-type natriuretic peptide reduces mucopolysaccharidosis-associated craniofacial hypoplasia in vivo
-
Studies on Cytotoxic Effects of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) to Canine Cell Lines Derived from Hemangiosarcoma and Mammary Epithelial Tumor
-
Molecular basis of lipid presenting and loading mechanisms of CD1b [an abstract of entire text]
-
miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1
-
CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy
-
The identification of novel small extracellular vesicle (sEV) production modulators using luciferase‐based sEV quantification method
-
CD204‑positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand‑1 expression
-
FE65 in breast cancer: its clinicopathological and biological significance
-
Antitumor Effect of Sclerostin against Osteosarcoma
-
SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization
-
B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4+ T cell responses in highly sensitized transplant recipients
-
B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4+ T cell responses in highly sensitized transplant recipients
-
The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B-cell lymphoma and enhances T-cell recruitment
-
l-Asparaginase regulates mTORC1 activity via a TSC2-dependent pathway in pancreatic beta cells
-
MECHANISTIC ANALYSIS OF THE INITIATION OF RETROVIRAL GENE SILENCING BY REPROGRAMMING FACTORS
-
アミノ酸およびペプチドによる食中毒細菌の生存とバイオフィルム形成の制御
-
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer
-
Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation
-
Protocol for the isolation of mouse senescence-associated CD4⁺ T cells using flow cytometry and functional assays
-
Establishment and Application of Anti-CD20 Monoclonal Antibodies using the Cell-based Immunization and Screening Method for the Detection of B Cells